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Tissues obtained from female Wistar rats exposed to a
0.9 (Jjn aerosol of 4,4'-methylenediphenyl diisocyanate
(MDI) for 17 h per day, 5 days per week, for one year, at
levels of 0, 03, 0.7 and 2.0 mg/m3, were analyzed for DNA
adducts. A 32P-postlabeling method was used to detect (i),
adducts formed by the reaction of the isocyanate group(s)
of MDI with DNA; and a 32P-postlabeling method was
adapted to detect (ii), a DNA adduct formed by 4,4'-
methylenedianiline (MDA), a hydrolysis/decarboxylation
product of MDI. In the lung, neither isocyanate adducts
nor the arylamine adduct were detectable. The same nega-
tive result was seen in the liver, the bladder, the kidney,
the respiratory epithelium and in peripheral lymphocytes.
In the olfactory epithelium, on the other hand, the aryl-
amine-derived DNA adduct was detected, at the very low
levels of 5,9 and 10 adduct-nucleotides per 1010 nucleotides,
for the three dose groups, respectively. The adduct co-
chromatographed with the one formed in the liver of rats
after oral gavage of MDA. The results are discussed in
terms of the importance of genotoxic versus nongenotoxic
aspects of carcinogenesis.
Introduction
4,4'-Methylenediphenyl diisocyanate (MDI*) and the corres-
ponding diamine 4,4'-methylenedianiline (MDA) are widely
used in the polymer industry. The main toxic effect of MDI
in humans is respiratory sensitization (1,2). Quantification of
specific antibodies to MDI covalently bound to human serum
albumin assists in the diagnosis of occupational asthma induced
by isocyanates (3,4). In a carcinogenicity study with Wistar rats
exposed to respirable technical MDI aerosol (50% monomeric
form; 93.5% of the particle sizes were below 4.2 um in
diameter), degeneration and basal cell hyperplasia of the nasal
olfactory epithelium, often accompanied by hyperplasia of
Bowman's glands, had been found in the 1.0 and 6.0 mg/m3
groups. In addition, eight pulmonary adenomas (six in 60 males
and two in 60 females) and one pulmonary adenocarcinoma (in
a male) had been observed in the 6.0 mg/m3 exposure group (5).
MDA induced neoplastic nodules in the liver of Fischer 344
rats and carcinomas in the liver of B6C3F1 mice, as well as
•Abbreviations: MDI, 4,4'-methylene diisocyanate; MDA, 4,4'-methylenedi-
aniline; MN, micrococcal nuclease; PDE, phosphodiesterease; pd units, pixel
density units; PNK, T4 polynucleotide kinase; RAL, relative adducl labeling;
RNase, ribonuclease; SD, standard deviation; TLC, thin-layer chromatography.
thyroid carcinomas in both species in a carcinogenicity study
with MDA added to the drinking water (6).
Both MDI and MDA can form macromolecular adducts.
Covalent binding of MDI can occur in two ways: isocyanate
adducts result from electrophilic reaction of the -N=C=O
group with the nucleophilic atoms of protein and DNA whereas
arylamine adducts could be formed following hydrolysis and
decarboxylation of MDI to the arylamine MDA (Figure 1).
Arylamines require enzymatic activation to form reactive
metabolites. MDI and MDA are positive in the Salmonella/
microsome mutagenicity assay upon addition of rat liver 9000
g supernatant (S9) (7-9). The positive result obtained with
MDI was seen only in the presence of a metabolic activation
system, suggesting that the mutagenic response was due to
arylamine adducts and not to isocyanate adducts.
In rat skin, isocyanate-DNA adducts were detected only at
the site of topical application (10). No isocyanate adducts
could be observed in liver, kidney, lung or bladder. Whether
arylamine adducts had been formed was not determined,
because the respective method of detection by 32P-postlabeling
was not available. In this report, the development of a 32P-
postlabeling method for the detection of MDA-derived DNA
adducts is described. DNA from various tissues of female
Wistar rats exposed to pure MDI aerosols (mainly monomeric
form) at dose levels of 0, 0.3, 0.7 and 2.0 mg/m3 were analyzed
for isocyanate and arylamine adducts, in order to answer the
question of whether DNA adduct formation represents a major
mechanism of toxic action of inhaled MDI.
Materials and methods
Chemicals and enzymes
Monomeric 4,4'-methylenediphenyl diisocyanate (MDI) (Desmodur44M) was
obtained from Bayer AG (Leverkusen, Germany) and 4,4'-methylenedianiIine
(MDA) from Fluka AG, Buchs, Switzerland. [y-32P]ATP (7000 Ci/mmol) was
supplied by ICN Biomedicals Inc (Irvine, CA). Ribonuclease A (RNase A, cat.
no. R-5125), ribonuclease T1 (RNase T1, cat. no. R-1003), phosphodiesterase II
(PDE, cat. no. P-6897), micrococcal nuclease (MN, cat. no. N-3755), nuclease
Pi (cat. no. N-8630) and apyrase (cat. no. A-6132) were purchased from
Sigma (St Louis, MO); proteinase K (cat. no. 82945) from Fluka (Buchs,
SG, Switzerland) and T4 polynucleotide bnase (PNK, cloned) from USB
(Cleveland, OH). Polyethyleneimine was supplied by Fluka (Buchs, SG,
Switzerland) and cellulose MN30I by Macherey and Nagel (Dflren, Germany).
All other chemicals were purchased either from Fluka (Buchs, SG, Switzerland)
or Sigma (St Louis, MO).
Animals, treatments and tissue collection
MDI exposure. Groups of 20 female Wistar rats (Crl:[WI]BR, Charles River
WIGA GmbH, Sulzfeld, Germany) were exposed in 6 m3-whole body
inhalation chambers at Fraunhofer ITA for 18 h per day nominally (on
average 17 h), 5 days per week for one year to monomeric MDI aerosols.
Recovery groups of 20 animals were kept in MDI-free air for I week after
the last exposure. At the beginning of the study, the rats were 10-weeks-old
with an average weight of 254 g, by the end of the study, the mean weight
was 510 g. For the DNA and protein adduct formation studies (11), five rats
per dose group were chosen randomly.
The mass median aerodynamic diameters of the aerosol particles had a
mean value of 0.95 ±0.12, 0.88 ± 0.13 and 0.93 ± 0.09 um, for the three
dose groups, respectively. The nominal concentrations in the inhalation
chambers were 0, 0.2, 0.7 and 2.1 mg/m3. The actual concentrations were
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Fig. 1. The two possible pathways for the formation of DNA adducts by
MDI: (left) the enzyme-independent reaction of nucleophiles with the
electrophilic isocyanate group of MDI forming isocyanate adducts; (right)
the enzyme-dependent reaction after hydrolysis of MDI to the carbamic acid
and decarboxylation to MDA with subsequent metabolic activation to
electrophilic nitrenium/carbenium ions forming arylamine adducts.
0 mg/m3 (control), 0.26 ± 0.06, 0.69 ± 0.17 and 1.99 ± 0.40 mg/m3. The
total mass concentration in each inhalation chamber was monitored using
light scattering aerosol sensors, which were calibrated by means of gravimetric
analysis of filter samples. The concentration of MDI in the aerosol was
determined from samples collected on PTFE filters and extracted with
acetonitrile. Gaseous MDI, which according to the vapor pressure occurs at a
concentration of approximately 80 |ig/m3- was collected by drawing the air
sample through a glass tube filled with glass wool impregnated with the
derivatizing agent, 4-nitro-yV-propylbenzylamine (NPBA). The determination
of NPBA-derivatized MDI was carried out by HPLC on a reversed phase
column with acetonitrile and water as solvents. MDA was not detectable in
the test atmosphere. Based on HPLC analysis, the fraction of monomeric MDI
was 35.9 ± 10.6%, 81.1 ± 10.7% and 87.9 ± 4 . 1 % for the low, middle and
high aerosol concentration, respectively, including the vapor form. Details of
the inhalation exposure will be published elsewhere.
The animals were killed by Nembutal i.p. and the blood was taken retro-
orbitally into EDTA tubes. Peripheral lymphocytes from five animals of each
dose group were isolated with Ficoll-Paque® (Pharmacia) and stored at -80°C
until 32P-postlabeling analysis was performed. Lung, liver, kidney, bladder
and the head were immediately frozen in liquid nitrogen. The respiratory and
olfactory epithelium was isolated as described (12), except that the epithelium
of the endo- and exoturbinates of the ethmoid turbinate were pooled for DNA
isolation. In the recovery group, more tissue was collected from the turbinates
of level IV of the nasal cavity (13). Between 120-300 ng DNA were isolated
from recovery group animals as compared to 70-190 |ig DNA from the
animals killed immediately after the end of the exposure.
MDA treatment. Three groups of three male Fischer 344 rats (~25O g) from
Charles River Savo, Kisslegg, Germany were treated by gavage on three
subsequent days with about 1 ml/kg body weight (b.wt) of an application
solution consisting of MDA dissolved in 2 ml dimethylsulfoxide and 18 ml
com oil. The dose was 4, 20 and 50 mg MDA/kg b.wt per day. Two control
rats received the vehicle only. Twenty-four hours after the third application
the rats were killed with Halothane and open heart puncture. The blood was
collected into heparinized tubes, peripheral lymphocytes were isolated with
Ficoll-Paque® (Pharmacia) and stored at -80°C. Liver and bladder were
immediately frozen in liquid nitrogen and stored at — 80°C.
32P-Postlabeling assay
DNA was isolated according to Beach and Gupta (14) with the following
modifications. The final concentration of RNase A and RNase Tl was 166 |ig/
ml and 100 U/ml, respectively. Sodium dodecyl sulfate (1%) was added prior
to proteinase K (200 u.g/ml) treatment. Thirty ng of liver DNA from the
rats treated orally with MDA were hydrolysed to the 3'-phosphates of
deoxyribonucleoside with 7.5 (ig MN and 7.5 (ig PDE for 4.5 h at 37°C in a
total reaction volume of 100 u.1, whereas 15 ng DNA samples from MDI-
exposed rats were digested with 5 |ig MN/5 ng PDE for 3 h at 37°C. Two uj
of the DNA digest were used for normal nucleotide analysis according to
Gupta and Randerath (15). Adducts were enriched by the butanol procedure
and the labeling reaction was performed as described (16), except that five
backwashes with water were performed to ascertain that [y-32P]ATP will be
in excess to the residual normal nucleotides and adducts in the labeling
reaction. Adduct sensitivity for nuclease PI was tested by the method described
(14). Aliquots of 160 u.Ci [y-32P]ATP were used per sample in a reaction
volume of 15 (al for 45 min at room temperature. Subsequent to the kinase
reaction, an incubation with I jig apyrase was performed for 30 min. Seven
u.1 from a total of 16 \l\ were applied to self-made polyethyleneimine-cellulose
sheets (15). Olfactory epithelium DNA was analyzed twice. For the second
run, 14 ul of the labeled solutions was used. Dl of the chromatography was
run opposite to D3 with 2 M sodium phosphate, pH 6, onto 5 cm of a
Whatman wick no 17. Adducts were resolved by two-directional thin-layer
chromatography (TLC). Isocyanate adducts were separated in D3 and D4 by
urea solvents as described (10). The arylamine adduct was subjected to
development in D3 with 3.1 M lithium formate, pH 3.4, containing 5.5 M
urea (LFU), followed by D4 with isopropanol: 4 M ammonia with a ratio of
0.7:1, onto 3 cm of a Whatman wick no. 1. Finally, the chromatograms were
cleaned (D5) with 0.28 M ammonia, onto 3 cm of a Whatman wick no. 1.
With the second analysis of olfactory epithelium DNA, a radioactivity
background front was seen in the adduct region. For further removal of
background radioactivity, therefore, an additional run opposite D4 was done
with 0.47 M sodium phosphate, pH 8.2,0.3 M Tris containing 4.9 M urea (SPU).
Detection and quantification of DNA adducts
Spots were either detected by autoradiography (liver of MDA-exposed rats
and olfactory epithelium of rats from the recovery group exposed to MDI
aerosols), and radioactivity in clearly visible spots was determined by Cerenkov
counting of a cutting of the TLC plates. 32P-Postlabeling analysis and
quantification of DNA samples from rats exposed to MDI aerosols and
the co-chromatography experiment were performed with a Phospho-Imager
(BIORAD). For the calibration of the Phospho-Imager, stripes with different
activities of '''strontium (Sr) were prepared and exposed for 4 h. The pixel
density units (pd units) of the '"Sr spots were transformed to [32P]-d.p.m.
values using the pd units of [y-32P]ATP spots after 4 h exposure time, and
whose radioactivity was determined by Cerenkov and liquid scintillation
counting with a Beckman LS 6000 counter in automatic quench control mode.
The 90Sr-stripes were co-exposed for 4 h with all TLC-plates screened in one
set and were re-used throughout the experiments. The background radioactivity
was determined in cuttings of the same size and at the same place from plates
used for analysis of control DNA. Cerenkov counting of the backgrounds for
liver DNA were 211 ± 6 c.p.m. (1 SD). At a significance level of three SD,
therefore, a minimum net DNA radioactivity of 3x6xV2 = 25 c.p.m. would
be required to be considered significant. Background counts for olfactory
epithelium DNA in the recovery group were 77 ± 6 c.p.m. (1 SD).
Determination of background counts with the Phospho-Imager yielded
69 ± 21 d.p.m. (1 SD). Net radioactivity was used to calculate the relative
adduct labeling (RAL) = net count in adduct spot divided by the net count
in the sum of the normal nucleotides, divided by the dilution factor (16). The
significance level of three SD was taken for the calculation of the limit of
detection. As positive controls, the arylamine adduct and the isocyanate
adducts from liver DNA of MDA-treated rats and DNA incubated with MDI
m vitro (10) were used, respectively.
The recovery of the arylamine adduct with the 32P-postlabeling analysis
was determined by comparison with DNA containing radiolabeled MDA
adducts. A liver sample from a male Sprague-Dawley rat which had been
treated intraperitoneally (i.p.) with 17.9 mg/kg [3H]MDA and killed after 65 h
was obtained from Dr P.Sagelsdorff, Ciba Geigy AG, Basle, Switzerland.
DNA was isolated according to published methods (17) and the specific
activity of 329 d.p.m7mg DNA corresponded to 70 adducts per 109 nucleotides.
Removal of all non-covalently bound radioactivity was presumed on the basis
of comparable specific activity in DNA isolated independently from the same
liver and repurified to constant specific activity. Nucleotide analysis of
liver DNA from [l4C]MDA-treated animals by HPLC had shown that all
radioactivity covalently bound to DNA was recovered in an adduct fraction
(to be published elsewhere). It can be assumed that the same was true for the
[3H]MDA-treated animals, since after normalization to the dose, the adduct
levels were comparable.
Adduct standards
Chemically synthesised deoxyguanosine 3'-phosphates adducted at carbon-8
of guanine with the JV'-acetylated, non-acetylated MDA and 4-methylaniline,
i.e. /V-(2'-deoxyguanosine-8-yl)bis(4-aminophenyl)methane, /V'-acetyl-A/-(2'-
deoxyguanosine-8-yl)bis(4-aminophenyl)methane and A'-(2'-deoxyguanosine-
8-yl)4-methylaniline, a gift provided by Dr D.Schfltze (18), were used as
putative standards.
Co-chromatography
For co-chromatography of adducts, 30 |ig DNA from the liver of a rat treated
with 20 mg MDA/kg b.wt/day (3 X). 30 ug DNA from the olfactory epithelium
and liver of a rat exposed to 2.0 mg/m3 MDI aerosol and 30 (ig DNA from
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Fig. 2. 32P-Postlabeling maps with a mixture of in vitro synthesized
deoxyguanosine 3'-phosphates adductcd at carbon-8 of guanine with the N'-
Ac-MDA (1), MDA (2) and 4-methylaniline (3) (left) and the in vivo
MDA-DNA adduct (—»; right) detected in the liver of rats treated orally
with MDA. The LFU/SPU solvent system was used.
the olfactory epithelium of a control rat were digested, enriched and labeled
with 224 nCi [f-32P]ATP per sample. After apyrase incubation, 50 mM Tris-
HC1, pH 9.5, 10 mM EDTA were added to reach a final volume of 30 (il.
Thirteen p.1 of the 32P-labeled solutions of liver DNA originating from the
MDA treated rat were applied to the chromatography sheet and 13 \i\ of 32P-
labeled solution of olfactory epithelium DNA from a rat exposed to MDI
were added onto the same origin.
Results
Isocyanate-DNA adducts
DNA from lung homogenates of rats exposed to MDI aerosols
were analyzed by the 32P-postlabeling method known to detect
isocyanate-DNA adducts (10). No adduct spot was seen with
a limit of detection of 0.7-3.0 adduct-nucleotides per 109
nucleotides, depending on the place of the adduct spots on the
TLC plate. The same negative result was observed in all other
tissues from these animals, i.e. in the liver, the bladder, the
kidney, the respiratory epithelium and in peripheral
lymphocytes.
Arylamine-DNA adduct(s)
32P-Analysis for the detection of MDA-derived DNA adducts
was established using liver DNA from animals treated by
gavage with MDA. One adduct spot was detectable which was
not identical with spots resulting from the labeling of the three
/V-(deoxyguanosine-8-yl) arylamine adducts (Figure 2). In the
LFU/SPU solvent system, the region of the in vivo arylamine
adduct lies within a diagonal radioactive zone, causing great
variation in the background levels. In order to reduce back-
ground radioactivity, the D4 urea solvent was replaced by
ammonia/isopropanol, resulting in the low limit of detection
of 3 adduct-nucleotides per 1010 nucleotides with liver DNA.
The respective RAL values were in linear proportion to the
dose applied (Figure 3). Nuclease PI treatment resulted in
complete loss of this adduct, i.e. the MDA-DNA adduct is
nuclease PI-sensitive like most other arylamine adducts (14).
32P-Postlabeling analysis of DNA isolated from the bladder
and from lymphocytes of these animals did not show any
treatment-related DNA-adduct spots.
In order to investigate what fraction of the total number of
MDA-DNA adducts could be detected with this single spot,
a 32P-postlabeling analysis was also performed on a DNA
sample with an adduct level of 70 adducts per 109 DNA
nucleotides that was isolated from the liver of an animal that
had been treated with tritiated MDA. The 32P-postlabeling
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Fig. 3. Adduct concentrations (RAL values) determined for one DNA-
adduct spot in liver DNA of male Fischer 344 rats treated by gavage with 4,
20 and 50 mg MDA/kg b.wt on three subsequent days and killed 24 h after
the last dose. Means ± 1 SD (n = 3). At 4 mg/kg, the SD was smaller than
half the symbol size.
B +C
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Fig. 4. (A) 32P-postlabeling maps of DNA isolated from the olfactory
epithelium of a control rat of the MDI aerosol study; (B) from the olfactory
epithelium of a rat exposed to 2.1 mg/m3 MDI aerosol for 1 year,
(C) from the liver of a MDA-treated rat; (D) the liver of the same animals
as in (B). Co-chromatography plate of (B + C). Calibration of the Phospho-
Imager by '"Sr spots which had been calibrated with 32P.
analysis of this DNA resulted in a RAL value of 1.1 ± 0 . 5
adduct-nucleotides per 109 DNA nucleotides. Therefore, the
recovery of the single detectable adduct was only 1-2% of the
DNA adducts present
In the lung of rats exposed to MDI aerosol, i.e. the target
organ for MDI induced tumors, no MDA-DNA adduct was
detectable. However, this adduct was seen at very low levels
in DNA of the olfactory epithelium. Co-chromatography of
DNA from the olfactory epithelium of MDI-exposed rats with
liver DNA from MDA-treated animals confirmed the co-
migration of the spots on the TLC-plate. The respective
postlabeling maps are shown in Figure 4. The adduct concentra-
tion increased with dose in a supralinear manner (Figure 5).
At the lowest dose of 0.3 mg/m3, which is only six times the
actual threshold limit value of 5 ppb, adduct spots were
detectable at concentrations of 5 ± 1 adduct-nucleotides per
1010 nucleotides. In the 0.7 mg/m3 dose group RAL values
were 9 ± 4 adduct-nucleotides per 1010 nucleotides, and in
the high dose group 10 ± 3 adduct-nucleotides per 1010
nucleotides. Since all DNA samples have been postlabeled in
one set, the interanimal variation should have been independent
on the labeling efficiency. Unexpectedly, the recovery group
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Fig. 5. Adduct concentrations (RAL values) determined in DNA isolated
from the olfactory epithelium of female Wistar rats exposed to MDI aerosol
for 1 year, without (A) and with (B) 1 week of exposure-free recovery.
Means ± SD (n = 5); dashed line: limit of detection.
showed higher adduct concentrations. This could be related
to either the more extensive collection of tissue from the
turbinates, which could contain highly adducted DNA and/or
to a decrease in cytotoxicity after stopping the exposure.
Regenerative cell division after cytotoxicity is associated with
a higher rate of DNA replication resulting in a dilution of the
DNA adduct concentrations. The limit of detection in olfactory
epithelium DNA was 4 adduct-nucleotides per 1010 nucleotides,
and in olfactory epithelium DNA from the recovery group 8
adduct-nucleotides per 1010 nucleotides.
In all other organs investigated from MDI-exposed rats (i.e.
in the liver, the bladder, the kidney, the respiratory epithelium
and peripheral lymphocytes) no MDA-DNA adduct spot was
above the limit of detection.
All DNA samples from a given tissue were analyzed
simultaneously together with an aliquot of a standard liver
DNA sample from a rat treated with 50 mg MDA/kg. RAL
values of these positive controls were 2.1 ± 1.4 adduct-
nucleotides per 108 nucleotides (« = 13), i.e. the coefficient
of variation for the independent postlabeling analyses was
66%.
Discussion
We had previously established a 32P-postlabeling method to
detect (i) DNA adducts derived from the action of the iso-
cyanate groups of MDI with DNA (10). In this study, the
development of a 32P-postlabeling assay is demonstrated for
the analysis of a DNA adduct formed with MDA, the arylamine
resulting from hydrolysis and decarboxylation of MDI with
subsequent metabolic activation to reactive intermediates. One
dose-dependent adduct spot was observed in liver DNA from
rats treated by gavage with MDA. Interestingly, this MDA-
DNA adduct was not identical with the N-(deoxyguanosine-8-
yl) arylamine derivates, which are the predominant DNA
adducts formed by the majority of arylamines (19). The
recovery of this single detectable adduct was 1-2% of the
adducts formed in liver DNA on the basis of [3H]adduct
radioactivity after administration of [3H]MDA. This recovery
rate should not be used for the calculation of the total adduct
concentration in chronically exposed animals. In view of
adduct-specific rates of repair, adduct profiles after acute
dosing are expected to differ from those seen under steady-
state conditions reached with chronic exposure.
In the rats treated chronically by inhalation with MDI
aerosol, DNA-adduct formation was detectable exclusively in
the nasal olfactory epithelium. In this tissue, degeneration and
1072
basal cell hyperplasia often accompanied by hyperplasia of
Bowman's glands, had been found in animals exposed by
inhalation to technical MDI aerosol (5). Rather unexpected,
the adduct formed was not an isocyanate adduct but an
arylamine DNA adduct. It is conceivable that the aerosol
particles and MDI in vapor phase could have been trapped
within the architecture of the ethmoid turbinates. Hydrolysis
and decarboxylation of MDI to MDA is likely to occur when
the MDI-loaded air is moistened in the upper respiratory tract.
Bioactivation of arylamines to DNA-reactive intermediates
had been observed in organs other than the liver (20,21), but
DNA-adduct formation by procarcinogens in the olfactory
epithelium had been shown so far only for polycyclic aromatic
hydrocarbons such as benzo[a]pyrene (22) and for nitrosamines
such as the tobacco specific 4-(N-methyl-A'-nitrosamino)-l-(3-
pyridyl)-l-butanone (23-25).
The dose-response curves for the MDA-DNA adduct in the
olfactory epithelium was supralinear. Interestingly, in the same
animals, hemoglobin adduct levels showed the same shape of
the dose-response curve (11). The ratio of protein adduct
formation in erythrocytes and DNA adduct formation in a
target tissue for toxicity, therefore, appeared to be constant
over the dose range tested.
The question arises why hemoglobin adducts were detectable
but not systemic DNA adduct formation. Three points might
explain the discrepancy: (i) protein contain stronger nucleo-
philic centers than DNA, resulting in a faster rate of adduct
formation, (ii) hemoglobin adducts are not repaired, and (iii)
the lifetime of erythrocytes is longer than the lifetime of most
cell types, thus allowing an accumulation of adducts over
longer periods of time.
In the lung, the target organ for tumor formation in the rat,
after inhalation exposure to technical MDI (5), no DNA-adduct
was detectable. This was unexpected in view of the data with
rat skin, where topically administered MDI (3 mg/cm2) had
been shown to reach DNA of epidermal cells and form
isocyanate-DNA adducts (10). The following considerations
could account for the discrepancy. First, due to the high
electrophilic reactivity of the isocyanates, only cells lining the
epithelium of the lung would be adducted by MDI. DNA was
isolated from lung homogenates so that potentially high adduct
concentrations in the cells close to the airways were diluted
by more remote cells. It would therefore be necessary to study
cell subpopulations in order to determine adduct concentrations
in cells at risk. Second, the surface load could have been too
low in the lung to form detectable adduct concentrations. It
was about 80-fold lower in lung when compared with the
olfactory epithelium, assuming 15% deposition of 1 |im
particles in the lung (26) with a surface area of 3900 cm2 (27)
and a 2% deposition in the skull and an olfactory epithelium
surface area of 6.6 cm2 (28). Third, the pathway for diffusion
of the MDI aerosol is longer in the bronchiolar/alveolar region
of the lung as compared to the turbinates of the olfactory
epithelium, leading to more pronounced hydrolysis/decarb-
oxylation of MDI to MDA in the lung. Since MDI is able to
react with MDA to form mixed ureas, the addition reaction
occurring at the outer surface of the aerosol can result in the
formation of chemically inert particles.
Lung tumor formation in the rat has been observed not only
upon exposure to DNA-reactive carcinogens, but also to
chemically inert particles. Comparison of carcinogenic potency
of chronically inhaled diesel exhaust and carbon black had
indicated that the organic fraction did not play the major role
MDA-DNA adduct in rats exposed to MDI
in the carcinogenicity of diesel exhaust in the lung of rats
(29). Although MDI-derived particles are expected to act
differently in the lung due to the different chemical composi-
tion, it is conceivable that factors such as chronic inflammatory
response, cell injury and cell proliferation influenced the
formation of tumors by MDI.
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